Ke Zheng
Shenyang, 110042, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
[Retracted] Ursolic acid suppresses the biological function of osteosarcoma cells.
Journal: Oncology letters
Published: June 19, 2023
Phantom Limb Pain and Sensations in Chinese Malignant Tumor Amputees: A Retrospective Epidemiological Study.
Journal: Neuropsychiatric disease and treatment
Published: December 30, 2020
Long noncoding RNA NR2F1-AS1 enhances the malignant properties of osteosarcoma by increasing forkhead box A1 expression via sponging of microRNA-483-3p.
Journal: Aging
Published: October 11, 2019
PTHR1 May Be Involved in Progression of Osteosarcoma by Regulating miR-124-3p-AR-Tgfb1i1, miR-27a-3p-PPARG-Abca1, and miR-103/590-3p-AXIN2 Axes.
Journal: DNA and cell biology
Published: September 20, 2019
Extracellular nanovesicles-transmitted circular RNA has_circ_0000190 suppresses osteosarcoma progression.
Journal: Journal of cellular and molecular medicine
Published: June 10, 2019
Circular RNA 0001785 regulates the pathogenesis of osteosarcoma as a ceRNA by sponging miR-1200 to upregulate HOXB2.
Journal: Cell cycle (Georgetown, Tex.)
Published: May 23, 2019
Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: April 25, 2019
Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: February 24, 2019
Ilex hainanensis Merr targets ITGAV to suppress the proliferation and metastasis of osteosarcoma cells.
Journal: OncoTargets and therapy
Published: February 16, 2019
Last Updated: 09/26/2026